CYTOKINETICS INC — Director's Dealing 2014

Feb 26, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2014-02-24

Reporting Person: Blum Robert I (Director, President & CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-02-24	Incentive Stock Option (right to buy)	$9.65	A	13517	Acquired	2024-02-24	Common Stock (13517)	Direct
2014-02-24	Non-Qualified Stock Option (right to buy)	$9.65	A	186483	Acquired	2024-02-24	Common Stock (186483)	Direct

Footnotes

F1: When the ISO and NQ dated 02/24/2014 are combined for a total grant of 200,000 shares, the option shall vest and become exercisable as to 200,000 shares divided into equal monthly installments such that the option shall be 100% vested on 02/24/2018.